Polo-like kinase 1 as a potential therapeutic target and prognostic factor for various human malignancies: A systematic review and meta-analysis
ObjectiveThe overexpression of polo-like kinase 1 (PLK-1) has been found in a broad spectrum of human tumors, making it an attractive prognostic tumor biomarker. Nowadays, PLK-1 is considered a cancer therapeutic target with clinical therapeutic value. The aim of the present study was to systematica...
Main Authors: | Ming-Wen Wang, Zhong Li, Li-Hong Chen, Ning Wang, Jian-Ming Hu, Jin Du, Li-Juan Pang, Yan Qi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.917366/full |
Similar Items
-
Polo-like kinase 1 is related with malignant characteristics and inhibits macrophages infiltration in glioma
by: Lin Luo, et al.
Published: (2022-12-01) -
Genetic Deletion of Polo-Like Kinase 2 Induces a Pro-Fibrotic Pulmonary Phenotype
by: Theresa A. Kant, et al.
Published: (2021-03-01) -
Potential Tumor Suppressor Role of Polo-like Kinase 5 in Cancer
by: Shengqin Su, et al.
Published: (2023-11-01) -
Prognostic significance of CDC20 expression in malignancy patients: A meta-analysis
by: Feng Xian, et al.
Published: (2022-11-01) -
Role of Polo-like Kinases Plk1 and Plk4 in the Initiation of Centriole Duplication—Impact on Cancer
by: Ingrid Hoffmann
Published: (2022-02-01)